Author: Keshta, Ahmed S.; Mallah, Saad I.; Zubaidi, Khaled Al; Ghorab, Omar K.; Keshta, Mohamed S.; Alarabi, Dalal; Abousaleh, Mohammad A.; Salman, Mustafa Thaer; Taha, Omer E.; Zeidan, Anas A.; Elsaid, Mahmoud F.; Tang, Patrick
Title: COVID-19 versus SARS: A Comparative Review Cord-id: ettvagku Document date: 2021_4_24
ID: ettvagku
Snippet: The two genetically similar severe acute respiratory syndrome coronaviruses, SARS-CoV-1 and SARS-CoV-2, have each been responsible for global epidemics of vastly different scales. Although both viruses arose from similar origins, they quickly diverged due to differences in their transmission dynamics and spectrum of clinical presentations. The potential involvement of multiple organs systems, including the respiratory, cardiac, gastrointestinal and neurological, during infection necessitates a c
Document: The two genetically similar severe acute respiratory syndrome coronaviruses, SARS-CoV-1 and SARS-CoV-2, have each been responsible for global epidemics of vastly different scales. Although both viruses arose from similar origins, they quickly diverged due to differences in their transmission dynamics and spectrum of clinical presentations. The potential involvement of multiple organs systems, including the respiratory, cardiac, gastrointestinal and neurological, during infection necessitates a comprehensive understanding of the clinical pathogenesis of each virus. The management of COVID-19, initially modelled after SARS and other respiratory illnesses, has continued to evolve as we accumulate more knowledge and experience during the pandemic, as well as develop new therapeutics and vaccines. The impact of these two coronaviruses has been profound for our health care and public health systems, and we hope that the lessons learned will not only bring the current pandemic under control, but also prevent and reduce the impact of future pandemics.
Search related documents:
Co phrase search for related documents- active area and acute ards respiratory distress syndrome: 1
- active area and acute infection: 1, 2
- active area and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- acute ards respiratory distress syndrome and liver enzyme: 1, 2, 3, 4
- acute cardiac injury and admission rate: 1, 2, 3
- acute cardiac injury and liver enzyme: 1
- acute infection and additional screening: 1, 2, 3, 4, 5
- acute infection and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute infection and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute infection diagnosis and additional screening: 1
- acute infection diagnosis and admission rate: 1
- acute respiratory syndrome and additional screening: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute respiratory syndrome and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and long immunity last: 1
Co phrase search for related documents, hyperlinks ordered by date